Andy Acker

Janus Henderson Investors

Andrew Baum

Pfizer

Kate Bingham

SV Health Managers

Jay Bradner

Amgen

Pablo Cagnoni

Incyte

Francesco De Rubertis

Medicxi

Judith Finegold

Capital Group

Richard Francis

Teva

Simeon George

SR One

Mark Goldsmith

Revolution Medicines

Yvonne Greenstreet

Alnylam

Ricardo Grieshaber-Bouyer

FAU Erlangen-Nürnberg

Jane Grogan

Biogen

Mary Lynne Hedley

Third Rock Ventures

Margaret (Peg) Horn

Revolution Medicines

Sui Huang

Institute for Systems Biology

Bob Hugin

Celgene Corporation (retired)

Kris Jenner

Rock Springs Capital

NOBEL

William Kaelin

Harvard Medical School

BREAKTHROUGH

Jeffery Kelly

The Scripps Research Institute

Richard Kogan

Weill Cornell Medicine

Adam Koppel

Bain Capital

Nello Mainolfi

Kymera Therapeutics

John Maraganore

Richard Mason

Apollo Therapeutics

Ira Mellman

Parker Institute for Cancer Immunotherapy (PICI)

NOBEL

Craig Mello

University of Massachusetts Medical School

John F. Milligan

Gilead Sciences

PULITZER

Siddhartha Mukherjee

Columbia University

Matthias Müllenbeck

Merck KGaA

Kabir Nath

Compass Pathways

Stephen O’Rahilly

University of Cambridge

Jane Osbourn

Alchemab

Christian Rommel

Bayer Pharmaceuticals

Andrew Scharenberg

Umoja Biopharma

Severin Schwan

Roche Holding

Chris Sheldon

GSK

Joanne Smith-Farrell

Be Biopharma

Otello Stampacchia

Omega Funds

Molly Stevens

University of Oxford

Scott Struthers

Crinetics

Zhen Su

Marengo Therapeutics

Nicki Thompson

TRIMTECH Therapeutics

Patrick Vallance

UK Department for Science, Innovation and Technology (DSIT)

Ethan Weiss

Marea

NOBEL

Greg Winter

University of Cambridge

Ola Wlodek

Constructive Bio